Episode Details

Welcome back, everyone. Today we're tackling something that could seriously affect a lot of Medicare patients out there—especially if you're dealing with chronic wounds, diabetic foot ulcers, or venous leg ulcers. Starting January first, twenty twenty-six, Medicare is rolling out some pretty significant changes to its Local Coverage Determination for Cellular and Tissue-Based Products—CTPs—also known as skin substitutes. These are used in outpatient wound care specifically for diabetic foot ulcers and venous leg ulcers. So, why should patients seek treatment now, before these reductions take effect? KureCare a division of Veracor Group LLC City: Miami Address: 1150 NW 72ND AVE Website: https://curewounds.com